Central Trust Company’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Central Trust Company’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-237	Closed	-$13K	–	1372
2017 Q4	$13K	Hold	237	–	–	﹤0.01%	949
2017 Q3	$14K	Hold	237	–	–	﹤0.01%	914
2017 Q2	$14K	Sell	237 -125	-35%	-$7.12K	﹤0.01%	908
2017 Q1	$20K	Buy	+362	New	+$17.8K	﹤0.01%	888

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Central Trust Company's BIVV Position: Q1 2018 in Review

Central Trust Company sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 237 shares — an estimated $13K sold.

Central Trust Company first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $20K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Central Trust Company reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Central Trust Company sold 237 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $13K.
Central Trust Company first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Central Trust Company's Bioverativ Inc. Common Stock position peaked at $20K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Central Trust Company's 13F filing for Q1 2018, filed 4 Apr 2018.